Keyphrases
COVID-19
100%
Pathophysiology
100%
Asymptomatic Carriers
30%
Supplemental Oxygen
23%
Recovery Time
15%
Sepsis
7%
Intensive Care Unit
7%
Public Health Interventions
7%
Fever
7%
Quantitative PCR
7%
Polymerase Chain Reaction Assay
7%
Hospital Discharge
7%
Antiretroviral Therapy
7%
Monoclonal Antibody
7%
Contact Tracing
7%
Case Fatality Rate
7%
Hospitalization
7%
Symptom Onset
7%
Lactate Dehydrogenase
7%
Intensive Care
7%
Pneumonia
7%
Rate Ratio
7%
Fatality
7%
COVID-19 Pandemic
7%
Preventive Strategies
7%
Clinical Intervention
7%
Randomized Trial
7%
Face Contact
7%
Clinical Investigation
7%
Lymphopenia
7%
Usual Care
7%
Multiorgan Disease
7%
28-day Mortality
7%
Anticoagulants
7%
Common Symptoms
7%
Fulminant Disease
7%
Convalescent Plasma
7%
Acute Respiratory Failure
7%
False-negative Test
7%
Social Distancing
7%
Ongoing Trials
7%
Respiratory Droplets
7%
Effective Management
7%
Age-adjusted Rate
7%
Elevated Lactate
7%
Laboratory Abnormalities
7%
Oxygen Demand
7%
Severe Symptoms
7%
Shortness of Breath
7%
Severe Acute Respiratory Syndrome coronavirus-2 Vaccine
7%
Face Mask
7%
Radiographic Abnormalities
7%
Hyperimmune Globulin
7%
Dry Cough
7%
Negative Test Results
7%
Prevention Management
7%
Remdesivir
7%
Supportive Management
7%
Immune Regulation
7%
Social Contact
7%
Acute Hypoxemic Respiratory Failure
7%
Medicine and Dentistry
COVID-19
100%
Pathophysiology
100%
Severe Acute Respiratory Syndrome Coronavirus 2
50%
Case Fatality Rate
20%
Disease
10%
Respiratory Failure
10%
Sepsis
10%
Intensive Care Unit
10%
Infection
10%
Intensive Care
10%
Public Health
10%
Dyspnea
10%
False Negative Result
10%
Contact Examination
10%
Coughing
10%
Horizontal Disease Transmission
10%
Antiviral Therapy
10%
Monoclonal Antibody
10%
Fulminant
10%
Social Distancing
10%
Asymptomatic Carrier
10%
Acute Respiratory Failure
10%
Lactate Dehydrogenase
10%
Lymphocytopenia
10%
Oxygen Consumption
10%
Remdesivir
10%
Hyperimmune Globulin
10%
Multiple Organ Dysfunction Syndrome
10%
Clinical Intervention
10%
Anticoagulant
10%
Dexamethasone
10%
Immunity
10%
Reverse Transcription Polymerase Chain Reaction
10%
Pharmacology, Toxicology and Pharmaceutical Science
Disease
100%
Coronavirinae
100%
Pathophysiology
100%
SARS Coronavirus
45%
Case Fatality Rate
18%
Infection
9%
Respiratory Failure
9%
Sepsis
9%
Disease Transmission
9%
Antiviral Therapy
9%
Coughing
9%
Monoclonal Antibody
9%
Anticoagulant Agent
9%
Dexamethasone
9%
Remdesivir
9%
Hyperimmune Globulin
9%
Lactate Dehydrogenase
9%
Multiple Organ Failure
9%
Acute Respiratory Failure
9%
Dyspnea
9%
Lymphocytopenia
9%
Nursing and Health Professions
Disease
100%
Pathophysiology
100%
Severe Acute Respiratory Syndrome
45%
Case Fatality Rate
18%
Infection
9%
Hospital Discharge
9%
False Negative Result
9%
Reverse Transcription Polymerase Chain Reaction
9%
Monoclonal Antibody
9%
Contact Examination
9%
Coughing
9%
Intensive Care
9%
Sepsis
9%
Rate Ratio
9%
Intensive Care Unit
9%
Respiratory Failure
9%
Disease Transmission
9%
Antiviral Therapy
9%
Lymphocytopenia
9%
Dexamethasone
9%
Hyperimmune Globulin
9%
Anticoagulant Agent
9%
Acute Respiratory Failure
9%
Lactate Dehydrogenase
9%
Remdesivir
9%
Multiple Organ Failure
9%
Dyspnea
9%
Face Mask
9%
Nutrition Policy
9%